Peptide Receptor Radionuclide Therapy (PRRT) of Neuroendocrine Tumor Patients with Carcinoid Heart Disease

被引：0
|
作者：
Prasad, V [1 ]
Secknus, M. A. [1 ]
Hoersch, D. [1 ]
Kuntze, T. [1 ]
Zachert, C. [1 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka, Bad Berka, Germany
来源：
NEUROENDOCRINOLOGY | 2009年 / 90卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [21] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [22] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
    Duan, Heying
    Ninatti, Gaia
    Girod, Bradley
    Ferri, Valentina
    Kunz, Pamela L.
    Fisher, George A.
    Moradi, Farshad
    Davidzon, Guido Alejandro
    Franc, Benjamin Lewis
    Iagaru, Andrei
    Mari, Carina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [23] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 456
  • [24] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [25] Clinical outcome of peptide receptor radionuclide therapy for patients with advanced neuroendocrine tumor
    Shibuki, T.
    Imaoka, H.
    Suzuki, H.
    Kano, D.
    Takahashi, K.
    Yanagisawa, K.
    Hirata, H.
    Akimoto, T.
    Ikeda, M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1329 - S1330
  • [26] The Use of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumor Cardiac Metastases
    Yu, Irene S.
    Funk, Gayle
    Lin, Eugene
    Kennecke, Hagen F.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (01) : e23 - e26
  • [27] PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
    Potter, Samara
    Johnston, Danielle
    Mahajan, Priya
    Venkatramani, Rajkumar
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [28] Peptide Receptor Radionuclide Therapy (PRRT) in 35 Patients with Metastatic Neuroendocrine Neoplasms (NENs): Overall Response and Toxicity
    Liotsou, T.
    Stefanoyiannis, A.
    Alexandraki, K.
    Koumarianou, A.
    Angelousi, A.
    Kaltsas, G.
    Chatziioannou, S.
    NEUROENDOCRINOLOGY, 2018, 106 : 253 - 253
  • [29] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Grade 3 Neuroendocrine Neoplasms: Safety and overall survival in 69 patients
    Zhang, J.
    Kulkarni, H.
    Singh, A.
    Niepsch, K.
    Mueller, D.
    Lehmann, C.
    Baum, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S587 - S588
  • [30] Long term assessment of renal function in patients with carcinoid heart disease under peptide receptor radionuclide therapy
    Prasad, V.
    Baum, R. P.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
12345